Research Projects & Grants

Internal

  • Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (02/2024 - 01/2025) Status: Completed
  • Bicalutamide plus leuprolide versus degarelix plus leuprolide as androgen deprivation therapy for patients with advanced or metastatic prostate cancer: A retrospective cohort study assessing incidence of tumor flare and cost-differences between each regimen, Role: PI, LLU Dept. of Pharmacy Practice, (11/2022 - 01/2024) Status: Completed
  • Investigator Initiated: A Retrospective chart review of patients treated with immune checkpoint inhibitors (ICI) to evaluate severe and fatal adverse events in the emergency department, Role: Investigator, LLU Dept. of Pharmacy Practice, (07/2021 - 10/2024) Status: Completed
  • Investigator Initiated: The bone-targeting agents and the need for electrolyte monitoring in cancer patients: A retrospective cohort study of cancer patients treated between January 1,2014 to June 24, 2020, Role: Investigator, LLU Dept. of Pharmacy Practice, (07/2020 - 09/2024) Status: Completed
  • Effects of chemotherapy on the concentration of minerals in hair, Role: Investigator, LLU Dept. of Allied Health Studies, (07/2019) Status: Completed
  • Risk Factors of Hypomagnesemia in Patients with Bone Metastases from Solid Malignancies Treated with Zoledronic Acid: A Single-institution Retrospective Study, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved
  • Cost analysis of subcutaneous daratumumab compared to intravenous daratumumab in multiple myeloma patients: A retrospective chart review, Role: Investigator, LLU Dept. of Pharmacy Practice, (11/2024) Status: Approved